Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01891383 |
Recruitment Status :
Withdrawn
(New data published showing EPO to be ineffective in TBI)
First Posted : July 3, 2013
Last Update Posted : January 18, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Dementia Traumatic Brain Injury (TBI) Mild Cognitive Impairment (MCI) Chronic Traumatic Encephalopathy (CTE) Post-traumatic Stress Disorder (PTSD) |
Study Type : | Observational |
Actual Enrollment : | 0 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | Endophenotypes of Dementia Associated With Traumatic Brain Injury in Retired Military Personnel |
Study Start Date : | July 2013 |
Estimated Primary Completion Date : | June 2016 |
Estimated Study Completion Date : | August 2016 |

Group/Cohort |
---|
History of TBI
The history of TBI will be assessed by the subject's answers to the Ohio State University Traumatic Brain Injury Identification Method Short Form (OSU TBI-ID SF).
|
No history of TBI
The history of TBI will be assessed by the subject's answers to the Ohio State University Traumatic Brain Injury Identification Method Short Form (OSU TBI-ID SF).
|
- Prevalence of dementia or MCI in the two groups (TBI versus no TBI) [ Time Frame: Single visit, 4 hours. ]The primary outcome will be the prevalence of dementia/MCI in the two groups (i.e. those with and without a TBI).
- Characterization of the types of dementia or MCI that occur in the two groups (TBI or no TBI) [ Time Frame: Single visit, 4 hours. ]The characterization of the dementia and cognitive impairment within the two groups based on the neuropsychological testing will be secondary outcomes of the study.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 95 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Cases (with a history of TBI):
- Ages 50-95 years
- History of traumatic brain injury of sufficient severity to have resulted in medical attention (ascertained via the Ohio State University TBI Identification Questionnaire—OSU TBI-ID, and based on DoD/VA criteria)
- Residence in AFRH-Washington D.C. or the Veterans Home of California-Yountville
- MMSE score ≥ 20
- Capacity to provide consent to participate in research (assessment made by study physician)
- Ability to read and write English
Controls (without a history of TBI):
- Ages 50-95 years
- No history of traumatic brain injury of sufficient severity to have resulted in medical attention (ascertained via the Ohio State University TBI Identification Questionnaire—OSU TBI-ID)
- Residence in AFRH-Washington or the Veterans Home of California-Yountville
- MMSE score ≥ 20
- Capacity to provide consent or assent to participate in research
- Ability to read and write English -
Exclusion Criteria:
Cases (with a history of TBI):
- History of penetrating brain injury
- History of disabling neurological or psychiatric condition such as epilepsy (besides posttraumatic epilepsy), multiple sclerosis, cortical stroke, hypoxic-ischemic encephalopathy, encephalitis, or schizophrenia
Controls (without a history of TBI):
History of disabling neurological or psychiatric condition such as epilepsy, multiple sclerosis, cortical stroke, hypoxic-ischemic encephalopathy, encephalitis, or schizophrenia

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01891383
United States, California | |
California Veterans Home-Yountville | |
Yountville, California, United States, 94599 | |
United States, District of Columbia | |
Armed Forces Retirement Home | |
Washington, District of Columbia, United States, 20011-8400 |
Principal Investigator: | Ramon Diaz-Arrastia, M.D., Ph.D. | Uniformed Services University of the Health Sciences | |
Principal Investigator: | Kristine Yaffe, MD | University of California, San Francisco |
Responsible Party: | Ramon Diaz-Arrastia, Director of Clinical Research, Center for Neuroscience and Regenerative Medicine; Professor of Neurology, Uniformed Services University of the Health Sciences |
ClinicalTrials.gov Identifier: | NCT01891383 History of Changes |
Other Study ID Numbers: |
ERMS# 12lO9006 NEU-92-1855 ( Other Identifier: USUHS ) |
First Posted: | July 3, 2013 Key Record Dates |
Last Update Posted: | January 18, 2019 |
Last Verified: | January 2019 |
Keywords provided by Ramon Diaz-Arrastia, Uniformed Services University of the Health Sciences:
Dementia Traumatic brain injury (TBI) Mild cognitive impairment (MCI) |
Chronic traumatic encephalopathy (CTE) Remote effects of TBI Post-traumatic stress disorder (PTSD_ |
Additional relevant MeSH terms:
Wounds and Injuries Dementia Brain Injuries Cognitive Dysfunction Brain Injuries, Traumatic Stress Disorders, Traumatic Stress Disorders, Post-Traumatic Brain Diseases Chronic Traumatic Encephalopathy Central Nervous System Diseases |
Nervous System Diseases Neurocognitive Disorders Mental Disorders Craniocerebral Trauma Trauma, Nervous System Cognition Disorders Trauma and Stressor Related Disorders Brain Injury, Chronic Neurodegenerative Diseases |